Apple
AAPL
Taylor Morrison Home
TMHC
D.R. Horton
DHI
Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
US Stock MarketDetailed Quotes
SIGA SIGA Technologies
- 5.570
- -0.160-2.79%
Close Mar 27 16:00 ET
- 5.570
- 0.0000.00%
Post 16:24 ET
397.90MMarket Cap6.79P/E (TTM)
5.760High5.560Low498.24KVolume5.730Open5.730Pre Close2.81MTurnover1.23%Turnover Ratio6.79P/E (Static)71.44MShares12.83052wk High1.84P/B225.61MFloat Cap5.16052wk Low--Dividend TTM40.50MShs Float23.227Historical High--Div YieldTTM3.49%Amplitude3.202Historical Low5.638Avg Price1Lot Size
About SIGA Technologies Company
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for medical needs and biothreats. The firm develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded by Steven Oliveira on December 28, 1995 and is headquartered in New York, NY.
Company Profile
SymbolSIGA
Company NameSIGA Technologies
Listing DateSep 9, 1997
Issue Price5.00
Founded1995
CEODr. Diem Nguyen, M.B.A.,PhD
MarketNASDAQ
Employees46
Fiscal Year Ends12-31
Address31 East 62nd Street
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10065
Phone1-212-672-9100
Websitehttp://www.siga.com
Company Executives
- Name
- Position
- Salary
- Dr. Diem Nguyen, M.B.A.,PhD
- Chief Executive Officer and Director
- --
- Dr. Dennis E. Hruby,PhD
- Executive Vice President and Chief Scientific Officer
- 1.81M
- Daniel J. Luckshire
- Executive Vice President, Chief Financial Officer, Corporate Secretary and Principal Accounting Officer
- 1.72M
- Julian Nemirovsky
- Independent Director
- 218.32K
- Joseph W. Marshall, III
- Independent Director
- 227.07K
- Jaymie A. Durnan
- Independent Director
- 206.58K
- Harold E. Ford, Jr
- Independent Director
- 200.50K
- Dr. Holly L. Phillips, M.D.
- Independent Director
- 210.33K
- Dr. Gary J. Nabel, M.D.,PhD
- Independent Director
- 209.08K
- General John M. Keane, (Ret.)
- Independent Director
- --
- Lawrence R. Miller
- General Counsel
- --
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
